Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sharps Technology Inc. - Common Stock (NQ: STSS )

0.3289 -0.0111 (-3.26%)
Streaming Delayed Price Updated: 12:11 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sharps Technology Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Sharps Technology And 2 Other Stocks Under $1 Insiders Are Buying
The Dow Jones index closed slightly lower on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
Via Benzinga
Topics Stocks
Exposures US Equities
Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems
--News Direct-- 
Via News Direct
Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems
Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal
--News Direct-- 
Via News Direct
Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal
Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic... 
Via Benzinga
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules for Sharps Technology, Inc. (NASDAQ: STSS)
Via ACCESSWIRE
Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Rises Sharply; Know Labs Shares Plunge
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 200 points on Wednesday. The Dow traded down 0.69% to 33,386.73 while the NASDAQ fell 0.50% to 12,997.99. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Dow Falls Over 100 Points; US Durable Goods Orders Increase In August
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 100 points on Wednesday. The Dow traded down 0.40% to 33,484.19 while the NASDAQ fell 0.12% to 13,047.47. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Open Higher; Costco Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.14% to 33,664.90 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. 
Via Benzinga
Sharps Technology, Inc. CEO is Featured in an Interview with SmallCapsDaily
NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily providing... 
Via TheNewswire.com
Sharps Technology, Inc. CEO is Featured in an Interview with SmallCapsDaily
NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily providing... 
Via NewMediaWire
RedChip Launches 'Small Stocks, Big Money' Podcast
Via ACCESSWIRE
Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! 
Via InvestorPlace
Sharps Technology Issues Update Letter To Shareholders From CEO Robert Hayes
Sharps Technology, Inc. (NASDAQ: STSS) (NASDAQ: STSSW) issued a shareholder update from Robert Hayes, the Company's Chief Executive Officer. Dear Fellow Shareholders: 
Via Benzinga
BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga 
Via TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.